KESTREL THERAPEUTICS Trademark
Trademark Overview
On Tuesday, December 17, 2024, a trademark application was filed for KESTREL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the KESTREL THERAPEUTICS trademark a serial number of 98906926. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, December 17, 2024. This trademark is owned by Kestrel Therapeutics Inc.. The KESTREL THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations; pharmaceutical preparations for use in oncology; pharmaceutical for preventing, diagnosing, treating and managing cancer; pharmaceutical preparations for inhibiting pan-oncogenic RAS proteins; therapeutic agents, namely, RAS protein inhibitors
Research and development in the fields of pharmaceuticals, cancer therapies, and oncogenic RAS proteins; providing medical scientific research information in the fields of pharmaceuticals, cancer therapies, and oncogenic RAS proteins
General Information
| Serial Number | 98906926 |
| Word Mark | KESTREL THERAPEUTICS |
| Filing Date | Tuesday, December 17, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Tuesday, December 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations; pharmaceutical preparations for use in oncology; pharmaceutical for preventing, diagnosing, treating and managing cancer; pharmaceutical preparations for inhibiting pan-oncogenic RAS proteins; therapeutic agents, namely, RAS protein inhibitors |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Research and development in the fields of pharmaceuticals, cancer therapies, and oncogenic RAS proteins; providing medical scientific research information in the fields of pharmaceuticals, cancer therapies, and oncogenic RAS proteins |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 17, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 17, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Kestrel Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Allston, MA 02134 |
Trademark Events
| Event Date | Event Description |
| Tuesday, December 17, 2024 | NEW APPLICATION ENTERED |
